SCIENTIFIC HUB

Araştırmanın izini sürün.

SCIENTIFIC LITERATURE · MED

Parkinson hastalığında bilişsel bozukluğun tespiti ve tahmini için makine öğrenme yöntemleri: sistematik bir inceleme ve meta-analiz.

Machine learning methods for the detection and prediction of cognitive impairment in Parkinson's disease: a systematic review and meta-analysis.

Makine çevirisi · Editoryal inceleme bekliyor

Front Aging Neurosci · 2025-12-11

DOI: 10.3389/fnagi.2025.1704039PMID: 41459340

Open accessSystematic Review; systematic-review; Journal ArticleKaynağa git ↗

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

BackgroundCognitive impairment in Parkinson's disease (PD-CI) is a prevalent non-motor symptom, significantly diminishing quality of life and imposing a substantial family burden. Effective predictive tools are currently scarce, and the diagnostic pathway is intricate. With the growing use of artificial intelligence in healthcare, machine learning (ML) methodologies have been explored for the diagnosis and early risk prediction of PD-CI; however, their efficacy and accuracy necessitate systematic evaluation. Consequently, this investigation undertook a systematic review and meta-analysis.MethodA comprehensive literature retrieval was conducted across Web of Science, PubMed, Embase, and Cochrane Library, encompassing studies published from database inception to August 10, 2025. The PROBAST tool facilitated quality appraisal, ultimately incorporating 52 publications, of which 25 addressed diagnosis and 27 focused on risk prediction.ResultsFindings indicated that within the validation cohorts, ML models for PD-CI diagnosis achieved a c-index of 0.82, with a sensitivity of 0.57 and specificity of 0.77. For PD-CI risk prediction, the c-index reached 0.83, accompanied by a sensitivity of 0.77 and specificity of 0.76. These results suggest that ML exhibits considerable accuracy in both the diagnosis and risk prediction of PD-CI. The models primarily incorporated variables such as clinical data, genetic characteristics, biomarkers, neuroimaging, and radiomics, and no overt signs of overfitting were detected.ConclusionThis research provides an evidence-based foundation for the future development of PD-CI risk prediction and intelligent diagnostic tools, thereby promoting the advancement and application of ML within Parkinson's disease and related domains.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, ID: CRD42023453586.

Bilimsel değerlendirme

01

Araştırma sorusu

Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.

02

Yöntem ve örneklem

Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.

03

Temel bulgular

Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.

04

Sınırlılıklar

Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.

Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.